Viewing Study NCT07105059

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-01-28 @ 3:53 AM
Study NCT ID: NCT07105059
Status: RECRUITING
Last Update Posted: 2025-11-28
First Post: 2025-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Teclistamab View
None Mezigdomide View
None Relapsed or refractory multiple myeloma View
None 24-393 View
None MATRIX (Mezigdomide And Teclistamab to Relieve Immune eXhaustion) View